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Whereas most nontyphoidal Salmonella (NTS) are associated with gastroenteritis, there has been a dramatic increase in
reports of NTS-associated invasive disease in sub-Saharan Africa. Salmonella enterica serovar Typhimurium isolates are
responsible for a significant proportion of the reported invasive NTS in this region. Multilocus sequence analysis of
invasive S. Typhimurium from Malawi and Kenya identified a dominant type, designated ST313, which currently is rarely
reported outside of Africa. Whole-genome sequencing of a multiple drug resistant (MDR) ST313 NTS isolate, D23580,
identified a distinct prophage repertoire and a composite genetic element encoding MDR genes located on a virulence-
associated plasmid. Further, there was evidence of genome degradation, including pseudogene formation and chromo-
somal deletions, when compared with other S. Typhimurium genome sequences. Some of this genome degradation in-
volved genes previously implicated in virulence of S. Typhimurium or genes for which the orthologs in S. Typhi are either
pseudogenes or are absent. Genome analysis of other epidemic ST313 isolates from Malawi and Kenya provided evidence
for microevolution and clonal replacement in the field.
[Supplemental material is available online at http://www.genome.org. The sequence data for S. Typhimurium strain
D23580 chromosome and pSLT-BT have been submitted to EMBL (http://www.ebi.ac.uk/embl/) under accession nos.
FN424405 and FN432031, respectively. The sequence data for A130 and 5579 have been submitted to the European Read
Archive under accession nos. ERA000075 and ERA000076, respectively, and are available at ftp://ftp.era.ebi.ac.uk/vol1/
ERA000/ERA000075/ and ftp://ftp.era.ebi.ac.uk/vol1/ERA000/ERA000076/.]
Bacterial genomes harbor both conserved core genome sequence,
shared within a species, and pan-genomic sequences that include
variable sequence, specific for clusters of isolates or clonal types
(Medini et al. 2005). The core genome encodes many of the genes
that define the species, whereas the pan-genome brings diversity
in terms of phenotype, including antigenic structure, metabolic
profile or, in the case of pathogens, virulence.
In Salmonella enterica, ;10% of any individual genome is
variable, including many horizontally acquired or mobile ele-
ments such as prophages, transposons, plasmids, and insertion
elements (McClelland et al. 2001; Parkhill et al. 2001a; Thomson
et al. 2008). S. enterica is a complex species composed of distinct
groups, referred to as serovars, which are defined by antigenic
structure and biotype. One of themost common serovars associated
with human and animal disease is S. enterica serovar Typhimurium
(S. Typhimurium). This serovar includes a number of variants
(pathovars) someofwhich are promiscuous in terms of their ability
to infect different livestock hosts and humans (e.g., DT104),
whereas others exhibit a restricted host range (e.g., DT2 and DT99)
(Rabsch et al. 2002). In humans, S. Typhimurium infection is
normally associated with self-limiting gastroenteritis (Zhang et al.
2003), and systemic disease is rare in most parts of the world.
However, a highly invasive form of nontyphoidal Salmonella (NTS)
disease, frequently associated with S. Typhimurium isolates, has
emerged as a major public health problem in sub-Saharan Africa
(Gilks et al. 1990; Vugia et al. 1993; Graham et al. 2000a; Berkley
et al. 2005; Kariuki et al. 2006a; Gordon et al. 2008). This disease is
characterized by bacteraemia and/or meningitis, with septic ar-
thritis also reported. The clinical presentation is nonspecific, with
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fever often the only clinical sign and a history of gastroenteritis
present in under half of all cases. Microbiological confirmation is
essential for making the diagnosis. Case-fatality rates are around
20%–25% for children and up to 50% in adults. NTS have infected
tens of thousands of people, replacing pneumococcus as the most
common cause of invasive bacterial disease in some parts of Africa
(Vugia et al. 1993; Berkley et al. 2005; Gordon et al. 2008). Invasive
NTS infections in adults are almost always associated with HIV-
positive individuals (Gordon et al. 2002), but less than one in five
cases in infants are HIV-associated, with malaria, anemia, and
malnutrition being the most common risk factors (Brent et al.
2006). Importantly, many NTS S. Typhimurium isolates causing
invasive disease are multiply antibiotic resistant, compromising
the clinical treatment of the disease (Gordon et al. 2008).
Although S. Typhimurium does not normally cause invasive
disease outside of sub-Saharan Africa, other S. enterica serovars do,
including S. Typhi and S. Paratyphi A. Infections caused by S. Typhi
and S. Paratyphi A are classically referred to as typhoid or enteric
fever. Like typhoid, invasive NTS infection is not always associated
with diarrhea (Raffatellu et al. 2008), but overall the diseases are
clinically distinct (Graham et al. 2000b; Gordon et al. 2002). Both
S. Typhi and Paratyphi A are host restricted to humans. In bacteria,
host restriction and change of ecological niche (gut to systemic
disease) have been linked to the accumulation of large numbers of
pseudogenes and an overall reduction in genome size. One or both
of these phenomena have been observed previously in other host-
restricted pathogens, includingYersinia pestis (Parkhill et al. 2001b;
Chain et al. 2004) and Mycobacterium leprae (Vissa and Brennan
2001).
Previous studies have provided indirect evidence that many
invasive S. Typhimurium isolates are genotypically related (Kariuki
et al. 2006a,b). These studies were performed using subgenomic
fingerprinting assays, such as pulsed-field gel electrophoresis
(PFGE)- or polymerase chain reaction (PCR)-based methodologies
that provide limited insight into phylogenetic and genomic re-
lationships. Although there is evidence that the genome of S.
Typhimurium is variable (Cooke et al. 2007), this variation has not
yet been linked to differences in pathogenicity between field iso-
lates. Here, we address the hypothesis that many S. Typhimurium
isolates that cause invasive disease in susceptible populations in
sub-Saharan Africa are phylogenetically distinct from other S.
Typhimurium isolates for which whole-genome sequence data are
available. We have used a combination of subgenomic assays and
whole-genome sequencing to characterize S. Typhimurium iso-
lates from invasive disease in two countries and a number of dis-
tinct geographical regions where such infections are common.
We provide evidence that a distinct phylogenetic lineage of S.
Typhimurium is a significant cause of invasive NTS disease. We
describe genome features, including evidence of genome degrada-
tion of genes previously implicated in host pathogen interactions,
suggesting that this lineage may represent a distinct pathotype of
S. Typhimurium.
Results
Novel sequence type (ST) variants of S. Typhimurium
are associated with invasive NTS in sub-Saharan Africa
S. Typhimurium is a common cause of invasive NTS disease in sub-
Saharan Africa, but little is known about the relationship of such
strains with those found in other regions of the world. We applied
multilocus sequence typing (MLST) (Maiden et al. 1998) analysis to
a collection of S. Typhimurium isolates from invasive disease in
urban and rural areas of the Blantyre region in Malawi, and from
both urban Nairobi and rural Kilifi in Kenya (Table 1). These data
were compared with ;400 isolates of S. Typhimurium for which
the ST has been deposited in a global MLST database (http://
www.mlst.net/) (Fig. 1). All 31 of the Malawian isolates and 13/20
of the Kenyan isolates were of a single MLST type, ST313. In
contrast to the dominance of ST313 in Kenya and Malawi, only
Table 1. Summary of bacterial strains used in this study
Strain
Country
of isolation Year Sourcea
Sequence
type
Phage
typeb
Resistance
profilec
A018 Malawi 1997 Blood 313 DT56var AKSuW
A082 Malawi 1997 Blood 313 DT56var AKSuWT
A130 Malawi 1997 Blood 313 DT56var AKSuW
A357 Malawi 1998 Blood 313 DT56var AKSuW
A665 Malawi 1998 Blood 313 DT56var AKSuW
A680 Malawi 1998 Blood 313 DT56var AKSuW
A3800 Malawi 1999 Blood 313 DT56var AKSuW
A4283 Malawi 1999 Blood 313 DT56var AKSuW
A4447 Malawi 1999 Blood 313 DT56var AKSuW
C2110 Malawi 2000 CSF 313 Untypable AKSuW
C2167 Malawi 2000 CSF 313 DT56 AKSuWT
C2364 Malawi 2000 CSF 313 DT56var AKSuW
A13198 Malawi 2001 Blood 313 DT56var AKSuW
A13212 Malawi 2001 Blood 313 DT56 AKSuWT
D11578 Malawi 2001 Blood 313 DT56var AKSuW
A16083 Malawi 2002 Blood 313 DT56var AKSuWT
D14916 Malawi 2002 Blood 313 DT56var CAKSSuWT
D15040 Malawi 2002 Blood 313 DT22 AKSuW
A24906 Malawi 2003 Blood 313 DT56var CAKSSuW
A24910 Malawi 2003 Blood 313 Untypable CAKSSuW
A24924 Malawi 2003 Blood 313 DT56var AKSuW
A32751 Malawi 2004 Blood 313 Untypable AKSuW
A32773 Malawi 2004 Blood 313 DT56var CAKSSuW
A32796 Malawi 2004 Blood 313 DT56var CAKSSuW
D23580 Malawi 2004 Blood 313 Untypable CAKSSuW
A38589 Malawi 2005 Blood 313 DT56var CAKSSuW
A38596 Malawi 2005 Blood 313 DT56var CAKSSuW
C13184 Malawi 2005 CSF 313 Untypable CAKSSuW
A39051 Malawi 2006 Blood 313 DT56var CAKSSuW
A39129 Malawi 2006 Blood 313 DT56var CAKSSuW
A39155 Malawi 2006 Blood 313 DT56var CAKSSuW
5521 Kenya 2003 Blood 313 — AKSSuW
5575 Kenya 2003 Blood 313 DT56var ASuW
5576 Kenya 2003 Blood 313 RDNC ASuW
5577 Kenya 2003 Blood 313 Untypable ASuW
5578 Kenya 2003 Blood 19 RDNC K
5579 Kenya 2003 Blood 313 Untypable CAKSSuW
5580 Kenya 2003 Blood 394 RDNC ASSuW
5581 Kenya 2003 Blood 313 DT193 ASuW
5582 Kenya 2003 Blood 313 Untypable AK
5597 Kenya 2003 Blood 313 Untypable AKSSu
5632 Kenya 2003 Blood 19 DT41 K
5634 Kenya 2003 Blood 19 DT56var K
5647 Kenya 2003 Blood 19 DT120 CAKSu
5912 Kenya 2004 Soil 313 DT56 ASuW
5964 Kenya 2004 Soil 313 DT56var CAKSuW
3697 Kenya NK Blood 313 RDNC NK
3762 Kenya NK Blood 19 DT193 NK
3831 Kenya NK Blood 313 DT193 NK
4191 Kenya NK Blood 19 DT193 NK
4246 Kenya NK Blood 313 Untypable NK
aBacterial strains were cultured from blood, soil, or cerebrospinal fluid
(CSF).
bRDNC, reacts does not conform.
cAntibiotic resistance profile. A, 10 mg of ampicillin; C, 30 mg of chlor-
amphenicol; K, 30 mg of kanamycin; S, 10 mg of streptomycin; Su, 200 mg
of compound sulphonamide; W, 5 mg of trimethoprim; NK, not known.
2280 Genome Research
www.genome.org
Kingsley et al.
 Cold Spring Harbor Laboratory Press on September 6, 2013 - Published by genome.cshlp.orgDownloaded from 
two other isolates of this ST from outside of sub-Saharan Africa
are currently in the S. entericaMLST database, which contains over
20 distinct STs of S. Typhimurium. Interestingly, both of these
other ST313 STs were isolated from cases of invasive NTS disease,
one in Scotland and the second in India. One other isolate from
Kenya thatwas assigned to ST394 is highly related to ST313 (Fig. 1).
The remaining six isolates from Kenya were of ST19, which is the
most common ST for S. Typhimurium in the database, with >220
entries. ST19 includes previously sequenced isolates of S. Typhi-
murium associated with classic gastroenteritis, including LT2,
SL1344, and DT104 NCTC13348. Most of the ST313 isolates de-
scribed in this study are of phage types DT56var or untypeable
(Table 1). Perhaps significantly, S. Typhimurium DT56var is fre-
quently isolated from wild birds, where they cause significant
mortality but are rarely isolated elsewhere from humans (Pennycott
et al. 2006).
The complete genome sequence of ST313 D23580
from Blantyre, Malawi reveals a novel prophage
repertoire and evidence of pseudogene accumulation
As ST313 is distinguishable by MLST from previously sequenced
S. Typhimurium isolates (Fig. 1), we determined the genome se-
quence of a representative isolate, D23580, that was isolated in
2004, at the peak of a Blantyremultidrug-resistant (MDR), invasive
NTS epidemic (MacLennan et al. 2008). The date of isolation of
D23580 corresponded with the emergence of resistance to chlor-
amphenicol, which was the antibiotic treatment of choice until
that time (Gordon et al. 2008). As might be expected, whole-ge-
nome comparisons between D23580 and LT2, SL1344, and DT104
NCTC13348 revealed extensive synteny and colinearity (Fig. 2).
However, in addition to representing a distinct MLST type, the
chromosome of D23580 had features that differentiated it from
S. Typhimurium strains LT2 (McClelland et al. 2001), DT104
NCTC13348, and SL1344, for which genomic sequence data had
previously been determined. For example, a comparison of the
genome of D23580 with SL1344 and DT104 NCTC13348 identified
a number of single nucleotide polymorphisms (SNPs) (Supplemental
Fig. 1), insertions, and deletions (Table 2; Supplemental Table 1).
One of the differentiating features was a distinct repertoire of
five prophage-like elements, designated BTP1 through BTP5 (Fig.
2; description in Supplemental text). Our analysis of the prophage
regions in the D23580 genome revealed that sseI that encodes
a Type III effector secreted by the Salmonella pathogenicity island
(SPI)-2 encoded type III secretion system, is a pseudogene. There-
fore, we analyzed all the pseudogenes present in D2380 and
compared these to the other sequenced S. Typhimurium. D23580
contained a total of 77 assignable pseudogenes, of which 23 were
specific to this strain (Table 2; Supplemental Table 1). Among
the D23580-specific pseudogenes are two, STM_MW29741 and
STM_MW10251, which are predicted to encode regulators and
may therefore affect expression of multiple genes. A number of
predicted transporters are also D23580-specific, including two
from the ABC transporter superfamily STM_MW09551 (ybjZ),
STM_MW30361, and an MFS-family transporter STM_MW15161
(ydeE). Eleven of the 23 pseudogenes that are specific for D23580
are also either pseudogenes or completely absent from S. Typhi or
S. Paratyphi A. These represent genes for which the respective
orthologous genes or genes in the same biosynthetic pathway in
S. Typhi or S. Paratyphi A are degraded. For example, the ratB gene
that encodes a secreted protein implicated in long-termpersistence
in the murine intestine (Kingsley et al. 2003) is inactivated by
a frameshiftmutation in S. Typhi and by a premature stop codon in
D23580. Additional orthologous pseudogenes are of currently
unknown function, but these may also reflect selection for con-
vergence in the evolution of these pathogens. Twelve D23580-
specific pseudogenes that are apparently intact in S. Typhi and S.
Paratyphi A as well as S. Typhimurium SL1344, DT2, and LT2, in-
clude the lpxO gene that encodes a putative dioxygenase required
for the synthesis of 2-hydroxymyristate modified lipid A (Gibbons
et al. 2000). This modification of the lipid bilayer is controlled by
the PhoPQ response regulator (Murata et al. 2007; Gibbons et al.
2008), a central regulator of Salmonella virulence genes that con-
tributes to resistance to host defenses including attack by cationic
peptides.
In addition to genome degradation due to pseudogene for-
mation, the genome of D23580 is ;15 kb shorter than SL1344,
excluding IS and prophage elements, due to four separate deletions
impacting a total of 20 genes (Table 2; Supplemental Table 1).
Figure 1. Radial phylogram showing the phylogenetic relationship of S.
enterica serovar Typhimurium sequence types (STs). The S. Typhimurium
STs (red and yellow circles) are rooted to S. Typhi (blue circle). The length
of the connecting line is proportional to the degree of divergence. S.
Typhimurium STs from various worldwide locations outside sub-Saharan
Africa SSA (red) and NTS STs predominantly from SSA (yellow) are in-
dicated.
Invasive NTS disease Salmonella Typhimurium
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These deleted regions encode a number of genes that have been
implicated in pathogenesis. For example, a deletion of 723bp re-
sults in loss of the 59 end of the pipD gene located in SPI-5. The pipD
gene has homology with dipeptidases in Lactobacillus spp. and is
required by S. Typhimurium for induction of fluid secretion in
bovine ileal loops (Wood et al. 1998) and persistence in a murine
systemic model (Lawley et al. 2006). A deletion of 3981 bp has
removed some or all of STM1548 through STM1553, which are of
unknown function. A 9568 bp deletion in a phage remnant
resulted in the deletionof at least twelve putative coding sequences
(CDSs), including pagO andmig-13, as well as a number of putative
phage-related genes. The pagO gene is regulated by the phoP/phoQ
two-component regulator that also influences the expression of
key virulence genes encoded on SPI-1 and SPI-2 (Gunn et al. 1998).
The mig-13 gene encodes a putative membrane protein that was
identified on the basis of up-regulation on invasion of cultured
macrophages (Valdivia and Falkow 1997). Both mig-13 and pagO
have been implicated in systemic persistence in a genome-wide
randommutagenesis screen (Lawley et al. 2006). Finally, a 1694 bp
deletion affects the allP and allB genes encoding allantoin per-
mease and allantoinase. Allantoin is used as a sole source of carbon
and nitrogen by many enteric bacteria following conversion to
glyoxylate by a pathway involving allantoinase (encoded by allB),
allantoate amidohydrolase (encoded by allC), and (S)-ureidoglycolate
hydrolase (encoded by allD) (Cusa et al. 1999). Interestingly, allP
and allB are also pseudogenes in S. Typhi (Parkhill et al. 2001a); allP
is a pseudogene in S. Paratyphi A (Holt et al. 2009); allS, a tran-
scriptional activator of the allD operon, is a pseudogene in S.
Gallinarum (Thomson et al. 2008). Perhaps significantly, S. Typhi,
and S. Paratyphi A are adapted to higher primates, and S. Gallinarum
is restricted to poultry. The loss of allantoinmetabolism in human-
and poultry-adapted pathogens may be explained by differences
in purine metabolism in the tissues of higher primates and avian
species. In lower mammals, urate, the breakdown product of pu-
rines, is converted to allantoin by the action of uricase, prior to
excretion. In contrast, humans, anthropoid apes and new-world
monkeys do not express uricase, and therefore allantoin is likely
not available in these hosts (Fujiwara and Noguchi 1995). Further-
more, 15 of 20 genes absent from D23580 are also either absent
or present as pseudogenes in S. Typhi and/or S. Paratyphi A
(Parkhill et al. 2001a; McClelland et al. 2004). With respect to
pseudogenes and deleted genes of D23580, taken together, these
data provide evidence that the genome of D23580 has undergone
a pattern of degradation distinct from LT2, SL1344, and DT104
NCTC13348.
Draft sequencing of a chloramphenicol sensitive isolate strain
from Blantyre (strain A130) and an MDR isolate from Kenya
(strain 5579)
The epidemic increase in the incidence of invasive NTS between
1997 and 2007 in Blantyre was associated with the emergence of
MDR S. Typhimurium (Gordon et al. 2008). In 1997, >90% of iso-
lates were resistant to cotrimoxazole and ampicillin but susceptible
to chloramphenicol, the treatment of choice at the time. An in-
crease in the proportion of chloramphenicol resistant (Cm-R) S.
Typhimurium isolates was first noted in early 2002, and by the end
of 2003 Cm-R was predominant, prompting a change to alternative
therapies such as ciprofloxacin or ceftriaxone (Gordon et al. 2008).
In order to further investigate the S. Typhimurium causing
invasive NTS disease during this period we generated draft se-
quences of S. Typhimurium A130 and S. Typhimurium 5579 using
a 454 Life Sciences (Roche) pyrosequencingmachine. S. Typhimurium
A130 is a chloramphenicol susceptible ST313 isolate from 1997,
prior to the emergence of the full MDR phenotype. A total of 680
contigs of >500 bp with an average coverage of 103 were assem-
bled from single-end reads. The ST313 S. Typhimurium strain 5579
was isolated from Nairobi, Kenya, in 2003. In this case, a total of
205 contigs of >500 bp with an average coverage of 203 were as-
sembled from paired end reads. Using these data we determined
the phylogenetic relationship of these isolates and the gene con-
tent. We also determined the presence or absence of pseudogenes,
when thesewere due to deletions or insertions greater than a single
base pair, or due to a nonsense SNP resulting in a ‘‘STOP’’ codon.
However, it was not possible to determine confidently the presence
or absence of pseudogenes from pyrosequencing data when this
Figure 2. Whole-genome comparison of S. Typhimurium LT2, D23580, and DT104 NCTC13348. ACT comparison (http://www.sanger.ac.uk/Software/
ACT/) of amino acid matches between the complete six-frame translations (computed using BLASTN) of the whole genome sequences of S. Typhimurium
LT2 (LT2), D23580, andDT104NCTC13348. The red bars between theDNA lines represent individual TBLASTXmatches,with invertedmatches colored blue.
Large chromosomal features are indicatedwith a horizontal line labeledwith the feature identity. These analyses indicate the overall colinearity and synteny of
the chromosome of sequenced S. Typhimurium isolates. Large insertions or deletions (mainly prophage elements) are labeled. Smaller indels described in the
text are not visible at this resolution.
Kingsley et al.
2282 Genome Research
www.genome.org
 Cold Spring Harbor Laboratory Press on September 6, 2013 - Published by genome.cshlp.orgDownloaded from 
was due to a single nucleotide indel, as this sequencing technology
is prone to generating frame-shift errors in homopolymeric tracts.
We identified 1542 SNPs in strains LT2, SL1344, DT104,
D23580, A130, and 5579, which were used to determine phylo-
genetic relationships and calculate relative divergence (Fig. 3). As
expected, the ST19 strains LT2 and DT104 NCTC13348, and the
ST313 isolates formed distinct clusters. Interestingly, A130 ex-
hibited some divergence from D23580. However, the Malawian
isolate D23580was very closely related to the Kenyan isolate 5579,
indicating that these isolates shared a common ancestor relatively
recently.
We surveyed the chromosome of S. Typhimurium 5579 and
A130 to determine the presence or absence of genomic degrada-
tion features identified in the genome of D23580 (Supplemental
Table 1). The chromosomal gene content of S. Typhimurium 5579
was similar to that of D23580, reflecting their recent ancestry. All
of the chromosomal deletions identified in
the D23580 chromosome relative to SL1344
and DT104 NCTC13348 were also present in
5579. As in D23580, the sseI gene is inter-
rupted by insertion of an IS200 element. All
of the assignable pseudogenes formed by
nonsense SNPs (STOP codons) were con-
served in D23580 and 5579. None of the
chromosomal deletions observed in the
chromosome of D23580 or 5579 were pres-
ent in the A130 chromosome, indicating
that these regions were all deleted in D23580
since divergence from the A130 lineage
(Fig. 3). In contrast, six of eight pseudogenes
caused by nonsense SNPs (STOP codons;
Table 2) were present in Al30 as well as
D23580, indicating that this form of genome
degradation occurred predominantly before
these lineages diverged and are therefore
older than the degradation due to deletions
observed in D23580 alone.
The virulence-associated plasmids harbor
composite Tn21-like transposons encoding
multiple antibiotic resistance genes
In common with many other NTS isolates
from invasive disease, S. Typhimurium
D23580 exhibits an MDR phenotype (Table
1). Four putative plasmids were detected in
D23580 by gel electrophoresis after plasmid
DNA extraction. In agreement, the genomic
analyses also identified four plasmids of 117
kbp (pSLT-BT), 84 kbp (pBT1), 2.6 kbp
(pBT2), and 1.4 kbp (pBT3). Plasmids pBT1–
pBT3 have not previously been described,
and appear to be cryptic, in that we could not
assign them an obvious phenotype (Supple-
mental Fig. 2). In contrast, pSLT-BT is closely
related to pSLT, a virulence-associated plas-
mid essential for systemic invasiveness of S.
Typhimurium in mice (Gulig et al. 1993).
Comparison of the sequence of pSLT with
pSLT-BT revealed extensive synteny overall,
save for a single large insert in pSTL-BT that
was absent from pSLT. This insertion re-
sembled a composite Tn21-like mobile element (Fig. 4; description
in Supplemental text). All the antibiotic resistance expressed by
D23580 (CAKSSuW; Table 1) can be explained by genes encoded
within this composite element, and no other resistance genes were
found in pBT1, pBT2, pBT3, or on the chromosome. Thus, the
antibiotic resistance phenotype of the invasive S. Typhimurium
D23580 can be explained by the possession of multiple-linked
antibiotic resistance determinants that are encoded by a plasmid
associated with virulence and invasion. The virulence-associated
plasmid of S. Typhimurium 5579 (pSLT-5579) was identical to
pSLT-BT with the exception of deletion of most of the left end of
the composite element that had similarity to pU302L. In contrast,
pSLT-A130 harbored a distinctly different composite Tn21-like el-
ement encoding antibiotic resistance genes located at a different
site from that on pSLT-BT and pSLT-5579 (Fig. 4; description in
Supplemental text). Core genetic features of the Tn21-like regions
Table 2. Genome degradation specific to S. Typhimurium strain D23580
STM (ID) STM_MW (ID) Gene Description
157 01631 — Putative outer membrane protein
522 NP allP Allantoin transport protein
523 NP allB Allantoinase
834 08851 ybiP Putative integral membrane protein
942 09551 — Putative ABC superfamily transport protein
1014 10251 — Probable regulation protein
1023 10351 — Hypothetical on gifsy-2 prophage
1051 10631 sseI Type III secretion effector protein (SPI-2)
1092 NP — Putative cytoplasmic protein
1093 NP — Putative cytoplasmic protein
1094 11041 pipD Similar to dipeptidase A
1228 — Putative periplasmic protein
1516 15161 ydeE Putative MFS family transport protein
1548 15471 — Putative ribosyltransferase-isomerase
1549 NP — Putative translation initiation inhibitor
1550 NP — Putative cytoplasmic protein
1551 NP — Putative cytoplasmic protein
1551’ NP — Hypothetical protein
1552 NP — Putative cytoplasmic protein
1637 16321 — Putative inner membrane protein
1862 NP pagO PhoP activated gene
1863 NP — Putative inner membrane protein
1864 NP — Putative inner membrane protein
1865 NP — Putative DNA invertase
1866 NP — Hypothetical
1868 NP mig-13 Phage tail assembly protein
1868’ NP — Lytic enzyme
1869’ NP — Hypothetical protein
1870 NP — RecE-like protein
1896 18781 — Putative cytoplasmic protein
1940 19221 — Putative cell wall associated hydrolase
2238 22681 — Putative phage protein
2514 25311 ratB Secreted protein
2589 26091 — Hypothetical in Gifsy-1 prophage
2680 26941 — Putative cytoplasmic protein
2932 28951 ygbE Putative inner membrane protein
3012 29741 — Putative transcriptional regulator
3075 30361 — Putative ABC-type cobalt transport system
3355 33531 — Tartrate dehydratase
3624 36131 yhjU Putative inner membrane protein
3745 37341 — Putative cytoplasmic protein
3768 37571 — Putative selenocysteine synthase
4196 41451 — Putative cytoplasmic protein
4286 42371 lpxO Putative dioxygenase
Genome degradation relative to strains LT2, SL1344, and DT104, and comparison of these features
with S. Typhimurium strains 5579 and A130, and S. Typhi Ty2, and S. Paratyphi A STM and
STM_MW indicate the systematic designation of coding sequences in S. Typhimurium LT2 and S.
TyphimuriumD23580, respectively; pseudogenes are indicated by their systematic ID genes that are
absent due to probable deletion are indicated NP (not present).
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of pSLT-BT and pSLT-A130 share some common features, but the
composite elements differ in detail, reflecting a complex evolu-
tionary history. Thus, the emergence of Cm-R in Blantyre may be
associated with clonal replacement of different ST313 clones with
distinct antibiotic resistance loci.
Evidence for clonal replacement of invasive MDR
S. Typhimurium during a Blantyre epidemic
Wewere interested in determining themolecular events that led to
the emergence of MDR in Blantyre during the period 1997–2007.
We considered two alternative hypotheses to explain the epide-
miological data. First, a single clone or clones may have been cir-
culating in the Blantyre region throughout the study period and
MDR emerged due to recruitment of a chloramphenicol resistance
locus in one or more clones, after which the resistant clones be-
came dominant. If this were the case, we would expect that the
chromosomal genotype of isolates prior to the emergence of MDR
would be identical to those exhibiting the MDR phenotype. Al-
ternatively, the emergence of MDR may have been the result of
clonal replacement by a distinct chromosomal genotype, or mul-
tiple genotypes, coupled with a distinct antibiotic resistance locus
or loci. If this were the case the chromosomal genotypes would be
distinct before and after the emergence of MDR. Prophage ele-
ments are hot spots for chromosome evolution in S. Typhimurium
(Thomson et al. 2004; Cooke et al. 2007) and represent one ap-
proach tomeasuring genetic differences in otherwise highly related
isolates. Therefore, oligonucleotide primer pairs were designed
based on known prophage insertion sites or internal prophage-
specific sequences present in D23580 and other sequenced
S. Typhimurium (Supplemental Fig. 3). PCR was then used to am-
plify genomic DNA template prepared from each of 31 clinical in-
vasive S. Typhimurium isolates from Blantyre (Supplemental Table
2). This analysis confirmed that the ST313 isolates are highly con-
served atmost of the loci harboring the targeted prophage elements
but significant genetic differences were detectable within pro-
phages BT2 and BT3. Importantly, PCR amplification of BTP2 and
BTP3 associated sequences (primer pairs E and F, Supplemental
Table 3) were able to discriminate between Cm-S ST313 isolated
early on and Cm-R ST313 isolated later in the Blantyre epidemic
(Table 1), suggesting that clonal replacement by a strain with
a distinct genotype was responsible for the emergence of MDR.
Primer pair E amplifies DNA across the sseI CDS within prophage
BT2 (Miao et al. 2003), whereas primer pair F amplifies across
a highly variable region associated with BT3 that is almost com-
pletely absent from D23580 (Supplemental Fig. 2).
In order to investigate the molecular events that led to the
emergence of Cm-R we then determined whether a similar com-
posite Tn21-like element to that found on the pSLT-BT of D23580
was present in the virulence plasmids of other Malawian isolates.
To this end, we used PCR with oligonucleotide primer pairs
designed to anneal to the regions flanking the composite element
found on pSLT-BT (primer pair P1; Supplemental Fig. 3). Under the
experimental conditions employed, the presence of a large in-
sertion at this site would prevent the amplification of a PCR
product and the absence of an insertion would result in the am-
plification of a 1.2-kbp product. Significantly, a 1.2-kbp product
was observed for all the Cm-S Malawian isolates, but a similar
PCR product was not observed for Cm-R isolates (Supplemental
Table 2), suggesting that the composite element locus was empty
in the Cm-S isolates. Furthermore, primer pairs designed to am-
plify fragments internal to the integron-like element (primer pairs
2 through 5), did not amplify a product from the Cm-S isolates,
except primer pair 6, which amplified an internal fragment of the
blaTEM-50 gene. However, products were generated with all these
primers using Cm-R DNA as a template. These data indicated that
while the antibiotic resistance locus of MDR isolates may be re-
lated, antibiotic resistance genes encoded by the Malawian strains
isolated prior to emergence of chloramphenicol resistance are
encoded at a different locus and on a distinct element or elements
by isolates with a distinct chromosomal genotype. This was con-
sistent with the presence of a Tn21-like element similar to that
identified in strain A130 by pyrosequencing.
Discussion
We show here that many S. Typhimurium causing invasive NTS in
different regions within sub-Saharan Africa belong to a distinct ST,
designated ST313. ST313 isolates harbor genomic signatures that
differentiate them from S. Typhimurium causing gastroenteritis in
other regions of the world including a novel repertoire of prophage
elements and evidence of genome degradation. Currently, it is not
known if ST313 isolates are also associated with gastroenteritis in
sub-Saharan Africa, and this awaits further epidemiological in-
vestigation. However, limited epidemiological analysis within the
Malawian and Kenyan study sites has not identified ST313 S.
Typhimurium as a significant cause of diarrhea in these specific
regions. A framework for a multisite program to address this
question has been proposed recently (Clemens 2009). Nonethe-
less, MLST analysis and comparative whole-genome analysis in-
dicated significant evolutionary distance between ST313 isolates
Figure 3. Radial phylogram based on chromosomal SNPs showing the
phylogenetic relationship of sequenced S. Typhimurium isolates. Branch
lengths indicate the number of SNPs, scale as indicated, separating the
sequenced isolates indicated by circles. ST19 isolates (red circles) and
ST313 isolates (yellow circles) are shown. The black square indicates the
ancestral root.
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and those of ST19 that include common gastroenteritis strains
around the world. ST313 isolates rarely have been reported outside
of sub-Saharan-Africa, although restricted geographical localiza-
tion may not be a feature of just this ST. D23580 and other ST313
isolates harbor a unique combination of prophage-like elements
and distinct composite mobile elements encoding antibiotic re-
sistance genes. Relatively little is known about how bacterial ge-
nomes evolve over time and what impact this variation may have
on pathogenicity. The evidence presented here indicates that
evolution outside of the core genome of S. Typhimurium may be
clinically significant. For example, the use of chloramphenicol for
the treatment of invasive S. Typhimurium infections appears to
have contributed to the clonal replacement of a Cm-S ST313 with
a Cm-R variant with a novel composite mobile element and dis-
tinct genomic signatures.
Analysis of the complete genome sequence of S. Typhimurium
D23580 suggests that ST313 S. Typhimuriummay have undergone
partial selective genome degradation with some similarities with
those host adapted Salmonella serovars that cause invasive disease
such as S. Typhi (Parkhill et al. 2001a; Holt et al. 2008), S. Paratyphi
A (McClelland et al. 2004), and S. Gallinarum (Thomson et al.
2008). D23580 harbors additional pseudogenes and deletions not
present in other S. Typhimurium, some of which have been linked
to virulence, including sseI, encoding a type III-secreted effector
protein and ratB, encoding a secreted protein associated with in-
testinal persistence in the murine model of infection. The S.
Typhimurium D23580 genome has also lost blocks of genes of
unknown function through large deletions, some of which are also
absent from S. Typhi (Table 3), such as STM1549–1553. In-
dependent mutations in S. Typhimurium D23580 and S. Typhi
have resulted in the convergent lack of allantoin uptake and me-
tabolism. Of 44 novel pseudogenes or deletions in strain D23580
relative to LT2, over half of these (26) are also degraded in S. Typhi
or S. Paratyphi A, in the form of pseudogenes or deletions.
The genome of strain A130 is not degraded to as large an ex-
tent as D23580, relative to SL1344 and DT104. None of the de-
letion events observed in D23580 are present in strain A130,
indicating that these events occurred since these two lineages di-
verged. Although it was not possible to confirm the pseudogene
status of most of the A130 orthologs that are pseudogenes in
D23580, due to limitations of the pyrosequence methodology, we
were able to confirm that six of eight pseudogenes caused by
nonsense SNPs were conserved. These data suggested that at least
some of the genome degradation, exclusively in the form of
Figure 4. Genes and homologous regions of pSLT-BT and pSKT-A130. A circular map of pSLT-BT shows predicted genes on the forward and reverse
strands on the outer circle (yellow). Genes with putative antibiotic resistance functions (red), integron- or transposon-related functions (blue), plasmid-
associated functions (green), antiseptic and mercury resistance functions (purple), miscellaneous functions (gray), and pseudogenes (brown) are shown.
Arrows below the pSLT-BT composite element gene map indicate the annealing site of oligonucleotide primers used to probe clinical isolates. Regions of
each locus with similarity to Tn21 are indicated.
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pseudogene formation, occurred before the D23580 and A130
lineages diverged. In contrast, genome degradation due to deletion
was restricted to the lineage leading to D23580 and strain 5579.
Indeed, that two of the deletions inD23580 are not observed in the
chromosome of the closely related strain 5579, indicates that
degradation is an ongoing process. The gene content and the
structure of the Tn21-like locus encoding antibiotic resistance on
the virulence plasmid of S. Typhimurium strains D23580 and 5579
were very similar. Strain D23580 was isolated from the Blantyre
region in 2004 and strain 5579 a year earlier fromNairobi in Kenya.
The isolation of these two strains in different regions of sub-
Saharan Africa suggests that there may be a connection between
the emergence of MDR in these two locations.
An association between the invasion-associated spv locus on
pSLT (Gulig et al. 1993; Guiney et al. 1995) with antibiotic re-
sistance genes is disconcerting because it suggests that antibiotic
usage may be selecting for the maintenance of virulence. A Tn21-
like element (t-ST4) within the pSLT virulence plasmid of S.
Typhimurium has been previously described (Villa and Carattoli
2005). t-ST4 was distinct from the Tn21-like composite element in
pSLT-BT in that t-ST4was composed of a Tn21 plus a Tn1696 type I
integron. A distinct antibiotic resistance associated genetic island
was reported in S. Typhimurium clinical isolates from Asturia,
Spain (Herrero et al. 2008). This island is flanked by a toxin/anti-
toxin system and by genes predicted to encode an iron uptake
system. A third antibiotic resistance locus was associated with the
virulence plasmid of S. Brandenburg, but the complete sequence of
this is not yet available (Martinez et al. 2007). Together these ob-
servations indicate that the virulence plasmid may act as a general
platform for multiple and varied capture of antibiotic, heavy
metal, and antiseptic resistance. The composite element detected
in at least two sites in the pSLT plasmid is a further example of
a high-throughput gene exchange platform facilitating the sam-
pling of genes collected from other bacteria in the environment.
In conclusion, we have exploited genome information to
investigate the properties of bacterial pathogens that are currently
circulating in nature and that contribute to the disease burden in
a clinical setting. The ST313 isolates described in this work are not
the only S. enterica that can cause invasive disease in humans, but
the evidence provided here indicates that they may be becoming
a prominent clone that has adapted to this niche and that they are
continuing to evolve by microevolution. This study illustrates
some of the advantages of a whole-genome approach to such
studies, particularly in defining the genetic basis of antibiotic re-
sistance and virulence potential. In future studies we plan to ex-
ploit this genomic information to undertake detailed studies on
the pathogenic potential of these strains and their epidemiology in
the field in terms of transmission routes.
Methods
Bacterial strains and culture conditions
Isolates of S. Typhimurium from Blantyre, Malawi, were cultured
from venous blood or cerebrospinal fluid of febrile patients at the
Queen Elizabeth Central Hospital (QECH) from 1997 to 2006, as
described previously (Gordon et al. 2008). Culture and identi-
fication of NTS were done using previously described protocols
(Kariuki et al. 2006a). For conjugation experiments Escherichia coli
TOP10 in which the aph gene was inserted into the fhuA gene was
used as the recipient strain. Bacteria were routinely cultured aero-
bically at 37°C in Luria-Bertani (LB) broth or LB with 1% agar. S.
Typhimurium strain D23580 was isolated from the blood of
a Malawian 26-mo-old child with malaria and anemia admitted to
QECH in January 2004. Antibiotic sensitivity was determined by
standard methodology (Supplemental text).
Sequence analysis
Sequence data forMLSTand of shotgun libraries for whole-genome
sequence determination (strain D23580) was determined using
dye terminator chemistry on ABI3730 automated sequencers from
PCR products amplified using oligonucleotide primers described
previously (Kidgell et al. 2002). Genomic sequences of the S.
Typhimurium strains A130 and 5579 were determined using a 454
Life Sciences (Roche) GS-FLX sequencer with standard protocols
(Margulies et al. 2005). The nucleotide sequences of S. Typhimurium
strain D23580 chromosome and pSLT-BT have been submitted
to EMBL (http://www.ebi.ac.uk/embl/) under accession numbers
FN424405 and FN432031, respectively. The raw pyrosequence data
for A130 and 5579 have been submitted to the international Short-
Read Archive (http://www.ncbi.nlm.nih.gov/Traces/sra/sra.cgi) un-
der accession numbers ERA000075 and ERA000076, repectively.
SNPs were identified by comparisonwith the LT2 finished genome
sequence using MUMmer (Kurtz et al. 2004). SNP allele data from
whole-genome sequence or MLST were used to fit a phylogenetic
tree using PhyML (Guindon and Gascuel 2003) and drawn using
a dendroscope. Additional descriptions of molecular biology tech-
niques used are described in the Supplemental text.
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